ALFA Filings
Every announcement, straight from the exchange
Every Genpharmasec financial results announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements
Genpharmasec approved unaudited half-year results and planned sale of its wholly owned subsidiary Clinigenome India. Company Secretary Hardik Makwana resigns effective 16 November 2026.
Genpharmasec Ltd reported revenue from operations of ₹49.7 Cr (+314.2% YoY) and a net loss of ₹0.2 Cr for Q1 FY27.
Genpharmasec Ltd reported revenue from operations of ₹55.4 Cr (+295.7% YoY) and net profit of ₹1.4 Cr for Q4 FY26.
Genpharmasec Limited reported its audited standalone and consolidated financial results for fiscal year 2026. The board also re-appointed M/s. Abhishek M Agrawal & Co. as internal auditors.